Medipharm Labs Corp T.LABS

Organigram Invests in Germany

[QContinuum1]

But this excerpt from the PR is what caught my eye.

"The German cannabis industry is poised for significant expansion following the recreational cannabis legal reforms enacted on April 1, 2024. According to BDSA estimates, Germany is expected to bring in ~USD$1.5 billion in total sales in 2024, set to grow to ~USD$3.7 billion by 2027. This remarkable growth is driven by a 30-50% increase in medical cannabis prescriptions since April 1, 2024, a likely result of the regulatory framework changes that may have accelerated the shift by consumers from the illicit market to the legal market."

A 30-50% increase in medical cannabis???  If the Germany numbers for Q2 and Q3 are not meteorically larger, then someone will need to answer as to why that is.

[okgonow]

totally agree with the last sentence especially!!!!!!!! compounded by being partnered with Strada  with their connections and ability to bring product to market thru their sales /distribution team!!!!!!

[mdjbrown]

QC1, especially when considering the following statement in Labs last German update In addition to STADA sales Summary of MediPharm Labs Business Operations in Germany Beacon Medical GMBH   Beacon Medical is a wholly owned subsidiary of MediPharm Labs. Located in Potsdam, the business holds a suite of German GMP medical cannabis licenses to import, wholesale and distribute

[QContinuum1]

Not sure how our partners stack up against Sanity Group.  Hoping that they do given the BAT investment in Sanity (and OGI) and their undoubted strategy team doing their DD. If Stada is #2 in oils, and our claim to fame is oils and the med market is increasing by 30-50%, something has to give/break.  That of course doesn't consider the other partners either as you've mentioned

[QContinuum1]

Turns out that Vayamed (who LABS apparently had(s) an agreement with is just arms length of Sanity.  How incestuous.  MediPharm Labs Completes a New Cannabis Oil Delivery to German Partner Vayamed   Published Oct 19, 2021 7:00am EDT New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity

[mdjbrown]

Globe says Organigram increases holdings in Europe 2024-06-26 08:26 ET - In the News The Globe and Mail reports in its Wednesday edition that Organigram Holdings has taken a minority stake in European cannabis company Sanity Group through a $21-million investment. A Canadian Press dispatch to The Globe quotes the Moncton-based cannabis producer saying that it may eventually advance another $4